Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

Cited by (999)

Items 401–500 of 999

  1. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
    Ana Isabel Chico, Jesús Moreno-Fernández, Diego Fernández‐García, Eva Solá · 2023 · Diabetes Therapy
  2. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England
    Conor Farrington, Roman Hovorka, Helen R. Murphy · 2020 · Diabetes Technology & Therapeutics
  3. Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes
    Peter Alexander Senior, Anna P. Lam, Kate Farnsworth, Bruce A. Perkins, RÉMI P.R. RABASA-LHORET · 2020 · Current Diabetes Reports
  4. Diabetology 4.0: Scoping Review of Novel Insights and Possibilities Offered by Digitalization
    Claudia Eberle, Stefanie Stichling, Maxine Löhnert · 2021 · Journal of Medical Internet Research
  5. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial
    Laya Ekhlaspour, Dan Raghinaru, Gregory P. Forlenza, ELVIRA M. ISGANAITIS, Yogish C. Kudva, David Wing-Hang Lam, Camilla M. Levister, Grenye O’Malley, Mei Mei Church, John W. Lum et al. · 2022 · Journal of Diabetes Science and Technology
  6. User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines
    Jaclyn A. Shepard, Marc D. Breton, Revital Nimri, Joseph Tarquin Foulkes Roberts, Timothy Street, David Charles Klonoff, Katharine D. Barnard-Kelly · 2020 · Journal of Diabetes Science and Technology
  7. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria
    Rodolfo Javier Galindo, Grazia Aleppo, Christopher G. Parkin, David A. Baidal, Anders L. Carlson, Eda Cengiz, Gregory P. Forlenza, Davida F. Kruger, Carol Joan Levy, Janet B. McGill et al. · 2022 · Journal of Diabetes Science and Technology
  8. Ready or not? Greater readiness for independent self‐care predicts better self‐management but not HbA1c in teens with type 1 diabetes
    Eveline R. Goethals, Lisa K. Volkening, LIANE J. TINSLEY, Lori M. Laffel · 2020 · Diabetic Medicine
  9. Development of the Extended Infusion Set and Its Mechanism of Action
    GINA ZHANG, Ohad Cohen, SARNATH CHATTARAJ · 2022 · Journal of Diabetes Science and Technology
  10. Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women with Type 1 Diabetes Prone to Hypoglycemia
    Alex Mesa, Clara Solà, Irene Vinagre, Daría Roca, Montse Granados, Irene Pueyo, Carla Cabré, Ignacio Conget, Marga Giménez · 2024 · Diabetes Technology & Therapeutics
  11. Blood glucose monitoring devices for type 1 diabetes: a journey from the food and drug administration approval to market availability
    Rahul Mittal, Nicole Koutras, Jonathan Maya, Joana R. N. Lemos, Khemraj Hirani · 2024 · Frontiers in Endocrinology
  12. Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents With Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial
    D. Steven Fox, Julia Ware, Charlotte K. Boughton, Janet M. Allen, Malgorzata E. Wilinska, Martin Tauschmann, Louise A Denvir, Ajay Thankamony, Fiona Campbell, Raj Paul Wadwa et al. · 2024 · Journal of Diabetes Science and Technology
  13. Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae et al. · 2024 · Diabetologia
  14. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1‐year real‐world assessment
    Alessandro Rizzi, Linda Tartaglione, Lorenzo Lucaccini Paoli, Maria Laura Leo, Valentina Popolla, Luca Viti, Annarita Barberio, Mauro A. S. Di Leo, Alfredo Pontecorvi, Dario Pitocco · 2024 · Diabetes Obesity and Metabolism
  15. Closed-Loop Control for Fluid Resuscitation: Recent Advances and Future Challenges
    Behnood Gholami, Wassim M. Haddad, James M. Bailey, William W. Muir · 2021 · Frontiers in Veterinary Science
  16. Closed‐loop technology: a practical guide
    Sara Hartnell, Julia Fuchs, Charlotte K. Boughton, Roman Hovorka · 2021 · Practical Diabetes
  17. Hybrid closed‐loop therapy with a first‐generation system increases confidence and independence in diabetes management in youth with type 1 diabetes
    Alison Roberts, Leanne Fried, Julie Dart, Martin I. de Bock, Janice M. Fairchild, Bruce R. King, Geoffrey R. Ambler, Fergus J. Cameron, Sybil A. McAuley, ANTHONY C. KEECH et al. · 2022 · Diabetic Medicine
  18. Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real world
    Amigó, Judit, Ortiz-Zúñiga, Ángel, de Urbina, Ana M. Ortiz, Sánchez, Mònica, Dos-Santos, Marcos, Abad, Mercè, Cuadra, Fátima, Simó, Rafael, Hernández, Cristina, Simó-Servat, Olga · 2023 · Diabetes Research and Clinical Practice
  19. User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics
    Natalie S. Chen, Charlotte K. Boughton, Sara Hartnell, Julia Fuchs, Janet M. Allen, Malgorzata E. Willinska, Ajay Thankamony, Carine E. de Beaufort, Fiona Campbell, Elke Elisabeth Fröhlich-Reiterer et al. · 2021 · Diabetes Care
  20. Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy
    Melissa‐Rosina Pasqua, Michael A. Tsoukas, Ahmad Haidar · 2021 · Journal of Diabetes Science and Technology
  21. Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry
    Richard Bailey, Sriya Donthi, Sarah Coseo Markt, Colin K. Drummond, Jennifer C. Cullen · 2022 · Journal of Diabetes Science and Technology
  22. A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes
    Elise Schlissel Tremblay, Allison S Bernique, Katherine Garvey, Christina M. Astley · 2023 · Journal of Diabetes Science and Technology
  23. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review
    Chiara Mameli, Giulia Marie Smylie, Alessio Galati, Biagio Rapone, Roque Cardona‐Hernandez, Gianvincenzo Zuccotti, Maurizio Delvecchio · 2023 · European Journal of Pediatrics
  24. Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
    Jothydev Kesavadev, Anjana Basanth, Gopika Krishnan, Arun Shankar, Geethu Sanal, Sunitha Jothydev · 2023 · Diabetes Therapy
  25. Efficacy, safety, and satisfaction with the Accu-Chek Insight with Diabeloop closed-loop system in subjects with type 1 diabetes: a multicenter real-world study
    Chico, Ana, Navas de Solís, Sol, Lainez, María, Rius, Ferran, Cuesta, Martín · 2023 · Diabetes Technology & Therapeutics
  26. Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022
    Sebastian Seget, Anna Tekielak, Ewa Rusak, Przemysława A. Jarosz-Chobot · 2023 · Pediatric Endocrinology Diabetes and Metabolism
  27. Prolonged Use of an Automated Insulin Delivery System Improves Sleep in Long-Standing Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia
    Susan Kohl Malone, AUSTIN M. MATUS, Anneliese J. Flatt, Amy J. Peleckis, Laura Grunin, Gary Yu, Sooyong Jang, James E. Weimer, Insup Lee, Michael Roehrhoff Rickels et al. · 2023 · Journal of Diabetes Science and Technology
  28. Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes
    Sara Yi Ling Folk, Janet Zappe, Kathleen Louise Wyne, Kathleen Marie Dungan · 2024 · Journal of Diabetes Science and Technology
  29. Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial
    Julia Ware, Charlotte K. Boughton, Janet M. Allen, Malgorzata E. Wilinska, Sara Hartnell, Ajay Thankamony, Tabitha L. Randell, Atrayee Ghatak, Rachel E.J. Besser, Daniela Elleri et al. · 2024 · Diabetes Care
  30. Randomized Crossover Comparison of Automated Insulin Delivery Versus Conventional Therapy Using an Unlocked Smartphone with Scheduled Pasta and Rice Meal Challenges in the Outpatient Setting
    Sunil Deshpande, Jordan E. Pinsker, Mei Mei Church, Molly M. Piper, CAMILLE C. ANDRE, JENNIFER S. MASSA, Francis J. Doyle, David M. Eisenberg, Eyal Dassau · 2020 · Diabetes Technology & Therapeutics
  31. The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial ( GOLD‐5 )
    Arndís Finna Ólafsdóttir, Jan Bolinder, Tim Heise, William H. Polonsky, Magnus Ekelund, Magnus Wijkman, Aldina Pivodic, Elsa Ahlén, Erik Schwarcz, Thomas Nyström et al. · 2020 · Diabetes Obesity and Metabolism
  32. Youth and parent preferences for an ideal AP system: It is all about reducing burden
    PERSIS V. COMMISSARIAT, Lindsay Roethke, Jennifer Finnegan, Zijing Guo, Lisa K. Volkening, Deborah Ann Butler, Eyal Dassau, STUART ALAN WEINZIMER, Lori M. Laffel · 2021 · Pediatric Diabetes
  33. Designing a Bioelectronic Treatment for Type 1 Diabetes: Targeted Parasympathetic Modulation of Insulin Secretion
    Elliott W. Dirr, Morgan E. Urdaneta, Yogi Patel, Richard D. Johnson, Martha Campbell‐Thompson, Kevin John Otto · 2020 · Bioelectronics in Medicine
  34. Navigating the Unique Challenges of Automated Insulin Delivery Systems to Facilitate Effective Uptake, Onboarding, and Continued Use
    Molly L. Tanenbaum, PERSIS V. COMMISSARIAT, Emma G. Wilmot, Karin Lange · 2024 · Journal of Diabetes Science and Technology
  35. Endocrine Complications of Cystic Fibrosis
    Andrea True Kelly, Brynn E. Marks, Michael S. Stalvey · 2022 · Clinics in Chest Medicine
  36. Maximizing Glycemic Benefits of Using Faster Insulin Formulations in Type 1 Diabetes: In Silico Analysis Under Open- and Closed-Loop Conditions
    Jenny L. Diaz C., Patricio H. Colmegna, Marc D. Breton · 2023 · Diabetes Technology & Therapeutics
  37. Patients’ opinions 10 years after receiving encapsulated porcine islet xenotransplantation without immunosuppression
    Shinichi Matsumoto, Adrián Abalovich, Shaun Wynyard, Mariana Estela Carulla, David Abalovich · 2023 · Xenotransplantation
  38. Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real‐world, multicentre study
    Laura E. Donaldson, Spiros Fourlanos, Sara Vogrin, Richard J. MacIsaac, Peter Grahame Colman, Sybil A. McAuley · 2023 · Internal Medicine Journal
  39. (Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise
    Rebecca Tanja Zimmer, Alexander Auth, Janis Schierbauer, Sandra Haupt, Nadine Bianca Wachsmuth, Paul Zimmermann, Thomas Voit, Tadej Battelino, Harald Sourij, Othmar Moser · 2023 · Diabetes Technology & Therapeutics
  40. Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes
    Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, JOHAN H. JENDLE, Bengt-Olov Tengmark, Anna Folino, Ekström Marie, Marcus Lind · 2024 · Journal of Diabetes Science and Technology
  41. Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes
    Klemen Dovč, Tadej Battelino · 2020 · Expert Opinion on Drug Delivery
  42. Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children
    Lucia Ferrito, Stefano Passanisi, Riccardo Bonfanti, Valentino Cherubini, Nicola Minuto, Riccardo Schiaffini, Andrea Enzo Scaramuzza · 2021 · Minerva Pediatrics
  43. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
    Francesca Porcellati, Stefania Di Mauro, Alessio Mazzieri, Alessandra Scamporrino, Agnese Filippello, Michelantonio De Fano, Carmine Giuseppe Fanelli, Francesco Purrello, Roberta Malaguarnera, Salvatore Piro · 2021 · Biomolecules
  44. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine
    Erin C. Cobry, Tyler Reznick-Lipina, Laura L. Pyle, Robert Slover, John F. Thomas, Guy Todd Alonso, Raj Paul Wadwa · 2021 · Diabetes Technology & Therapeutics
  45. Multi-Task Disentangled Autoencoder for Time-Series Data in Glucose Dynamics
    Min Hyuk Lim, Young Min Cho, Sungwan Kim · 2022 · IEEE Journal of Biomedical and Health Informatics
  46. Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know
    Robert van Wilpe, Abraham Hendrikus Hulst, Sarah E. Siegelaar, J. Hans DeVries, Benedikt Preckel, Jeroen Hermanides · 2022 · Journal of Clinical Anesthesia
  47. Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes
    Claire J. Hoogendoorn, Raymond Hernandez, Stefan Schneider, Mark Harmel, Loree T. Pham, Gladys Crespo-Ramos, Shivani Agarwal, Jill P. Crandall, Anne L. Peters, Donna Spruijt‐Metz et al. · 2023 · Journal of Diabetes Science and Technology
  48. Standardized Hybrid Closed-Loop System Reporting
    Viral N. Shah, Satish K. Garg · 2020 · Diabetes Technology & Therapeutics
  49. Automated insulin dosing systems: Advances after a century of insulin
    Hood Thabit, Rayhan Lal, Lalantha Leelarathna · 2021 · Diabetic Medicine
  50. A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
    Jean‐Pierre Riveline, Jean‐Baptiste Julla, Élisabeth Bonnemaison, Michaël Joubert, Sandrine Lablanche, Agnes Sola‐Gazagnes, Delphine Demarsy, D. Gouet, Pauline Schaepelynck, Chloé Amouyal et al. · 2025 · Diabetes Obesity and Metabolism
  51. Research progress in the application of time in range: more than a percentage
    Jintao Wan, Jingyi Lu, Cheng Li, Xiaojing Ma, Jian Zhou · 2023 · Chinese Medical Journal
  52. Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting
    Nancy Samir Elbarbary, Eman Abdel Rahman Ismail · 2023 · Diabetology & Metabolic Syndrome
  53. Changes in A1C Versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes
    Eslam Montaser, Sebastián E Abad, Viral N. Shah · 2025 · The Journal of Clinical Endocrinology & Metabolism
  54. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol
    Julia Fuchs, Janet M Allen, Charlotte K. Boughton, Malgorzata E. Wilinska, Ajay Thankamony, Carine E. de Beaufort, Fiona Campbell, James Yong, Elke Froehlich‐Reiterer, Julia Katharina Mader et al. · 2021 · BMJ Open
  55. Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes: A Scoping Review
    Tim Hropot, Tadej Battelino, Klemen Dovč · 2022 · Hormone Research in Paediatrics
  56. Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed‑loop systems: A pilot study
    Selmen Wannes, Gehad Mohamed Gamal, Manel Ben Fredj, Dhai Al Qusayer, Sameh El Abed, Yasser Sedky, Munther Khalil · 2023 · Diabetes Research and Clinical Practice
  57. Mise en place de l’insulinothérapie automatisée en boucle fermée : position d’experts français
    Sylvia Franc, Pauline Schaepelynck, Nadia Tubiana‐Rufi, Lucy Chaillous, Michaël Joubert, Éric Renard, Yves Reznik, Charlotte Abettan, Élise Bismuth, Jacques Beltrand et al. · 2020 · Médecine des Maladies Métaboliques
  58. Hybrid Closed-Loop Control with Ultrarapid Lispro Compared with Standard Insulin Aspart and Faster Insulin Aspart: An In Silico Study
    Sylvain Lachal, Yousra Tourki, Sylvia Franc, Erik Huneker, Guillaume Charpentier, Pierre‐Yves Benhamou · 2021 · Journal of Diabetes Science and Technology
  59. Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study
    Gregory P. Forlenza, Tim Vigers, Cari Berget, Laurel H. Messer, Rayhan Lal, Marina Basina, David M. Maahs, Korey K. Hood, Bruce A. Buckingham, Darrell M. Wilson et al. · 2021 · Diabetes Technology & Therapeutics
  60. Adolescence and Emerging Adulthood
    Charlotte Wang Chen, Lori M. Laffel · 2024 · Wiley eBooks
  61. The insulin-only bionic pancreas improves glycemic control in non-Hispanic White and minority adults and children with type 1 diabetes
    Castellanos, Luz E., Russell, Steven J., Damiano, Edward R., Beck, Roy W., Shah, Viral N., Bailey, Ryan, Calhoun, Peter, Bird, Keisha, Mauras, Nelly, Bionic Pancreas Research Group et al. · 2023 · Diabetes Care
  62. Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
    Peter G. Jacobs, Carol Joan Levy, Sue A. Brown, Michael Charles Riddell, Ali Çınar, Charlotte K. Boughton, Marc D. Breton, Eyal Dassau, Gregory P. Forlenza, Robert J. Henderson et al. · 2025 · Journal of Diabetes Science and Technology
  63. Frequency and Causes of Nocturnal Alarms in Youth and Young Adults With Type 1 Diabetes Using a First-Generation Hybrid Closed-Loop System
    Erin C. Cobry, Tim Vigers, Cari Berget, Laurel H. Messer, Raj Paul Wadwa, Laura L. Pyle, Gregory P. Forlenza · 2023 · Diabetes Spectrum
  64. Addressing disparities in technology use among patients with type 1 diabetes: a review
    Sarah Kanbour, Estelle Marla Everett · 2023 · Current Opinion in Endocrinology Diabetes and Obesity
  65. Disordered Eating Behaviors Among Adolescents and Young Adults with Type 1 Diabetes Treated with Insulin Pumps and Hybrid Closed-Loop Systems
    Tamar Propper‐Lewinsohn, Roni Elran‐Barak, Michal Gillon‐Keren, Michal Yackobovitch‐Gavan, Alon Liberman, Moshe Phillip, Shlomit Shalitin · 2023 · Diabetes Technology & Therapeutics
  66. Alternative therapeutic strategies in diabetes management
    Alessia Annicchiarico, Barbara Barile, Cinzia Buccoliero, Grazia Paola Nicchia, Giacomina Brunetti · 2024 · World Journal of Diabetes
  67. Advances in diabetes technology to improve the lives of people with cystic fibrosis
    Kevin J. Scully, Brynn E. Marks, Melissa S. Putman · 2024 · Diabetologia
  68. Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related Complications
    DALTON R. BUDHRAM, Priya Bapat, ABDULMOHSEN M.K. BAKHSH, Mohammad I. Abuabat, Natasha J. Verhoeff, Doug Mumford, Andrej Orszag, Akshay Jain, David Z.I. Cherney, Michael Fralick et al. · 2024 · Canadian Journal of Diabetes
  69. Real-Life Use of Automated Insulin Delivery in Individuals With Type 2 Diabetes
    Chiara Fabris, Boris P. Kovatchev · 2024 · Journal of Diabetes Science and Technology
  70. Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
    Yongwen Zhou, Alisa Boucsein, Venus R. Michaels, Madeleine K. Gray, Craig Jefferies, Esko J. Wiltshire, Ryan G. Paul, Amber Parry‐Strong, Maheen Pasha, Goran Petrovski et al. · 2025 · Diabetes Obesity and Metabolism
  71. Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery
    Matilda M.E. Johansson, Francesc March de Ribot, Mary-Jane Sime, Alisa Boucsein, Yongwen Zhou, Craig Jefferies, Ryan G. Paul, Esko J. Wiltshire, Mary Binsu Abraham, Timothy W. Jones et al. · 2025 · Diabetes Technology & Therapeutics
  72. A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 Diabetes
    Banshi Saboo, Satish K. Garg, Richard M. Bergenstal, Tadej Battelino, Antonio Ceriello, Pratik Choudhary, Martin I. de Bock, Nancy Samir Elbarbary, Gregory P. Forlenza, Ana María Gómez et al. · 2025 · Diabetes Technology & Therapeutics
  73. A Comparative Study of Transformer-Based Models for Multi-Horizon Blood Glucose Prediction
    Meryem Altın Karagöz, Marc D. Breton, Anas El Fathi · 2025 · IFAC-PapersOnLine
  74. A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes
    Sonia Gera, Jaisree Iyer, S. Spence Meighan, Christine A. March, Brynn E. Marks · 2025 · Endocrine Practice
  75. Artificial Pancreas Technology Offers Hope for Childhood Diabetes
    Melissa J. Schoelwer, Mark Daniel DeBoer · 2021 · Current Nutrition Reports
  76. Diabetic Ketoacidosis in a Patient With Type I Diabetes Treated With a Closed-Loop Sensor–Augmented Insulin Infusion System
    Pranjali P Sharma, Ana Ramirez Berlioz, Angela D Weisz · 2023 · AACE Clinical Case Reports
  77. RETRACTED: Reverse iontophoresis generated by porous microneedles produces an electroosmotic flow for glucose determination
    Qi-yao He, Jia-hao Zhao, Shi-ming Du, D.D. Li, Zhiwei Luo, Xueqiu You, Jing Liu · 2023 · Talanta · Retracted
  78. Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study
    Tomoaki Akiyama, Tadashi Yamakawa, Kazuki Orime, Masahiro Ichikawa, Marina Harada, Takumi Netsu, Ryoichi Akamatsu, Keita Nakamura, Satoru Shinoda, Yasuo Terauchi · 2023 · Journal of Diabetes Investigation
  79. Where Do We Stand with Closed-Loop Systems and Their Challenges?
    Melanie A. Jackson, Jessica R. Castle · 2020 · Diabetes Technology & Therapeutics
  80. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies
    Mark P. Christiansen, Amy K. Bartee, Amy Lalonde, Richard E. Jones, Michelle L. Katz, Howard A. Wolpert, Ronald Brazg · 2020 · Diabetes Technology & Therapeutics
  81. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention
    Laura Marie Nally, Julie Ann Wagner, Jennifer L. Sherr, EILEEN M. TICHY, Kate Weyman, Meredith K. Ginley, Kristyn Zajac, Marcia Desousa, Veronika Shabanova, Nancy M. Petry et al. · 2020 · Endocrine Practice
  82. The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial
    Pierre‐Yves Benhamou, Sandrine Lablanche, A. Vambergue, Sylvie Pou, Stéphanie Madrolle, Hector M. Romero Ugalde, Sylvia Franc, Guillaume Charpentier · 2022 · Diabetes Obesity and Metabolism
  83. Artificial pancreas systems: experiences from concept to commercialisation
    David L. Rodríguez-Sarmiento, Fabian Mauricio León Vargas, G. Maira · 2022 · Expert Review of Medical Devices
  84. Toward Automated Insulin Delivery
    Daniela Bruttomesso · 2019 · New England Journal of Medicine
  85. Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
    Grazia Aleppo, Christopher G. Parkin, Anders L. Carlson, Rodolfo Javier Galindo, Davida F. Kruger, Carol Joan Levy, Guillermo E. Umpierrez, Gregory P. Forlenza, Janet B. McGill · 2021 · Diabetes Technology & Therapeutics
  86. Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time
    Boris P. Kovatchev, Benjamin J. Lobo · 2023 · Diabetes Technology & Therapeutics
  87. The role of technology in the care of diabetes mellitus in pregnancy: an expert review
    Sydney Marie Thayer, Kelley J. Williams, Megan L. Lawlor · 2023 · AJOG Global Reports
  88. User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative study
    Shekhar Sehgal, Martin I. de Bock, Shirley Jones, Carla M. Frewen, Benjamin John Wheeler · 2023 · Frontiers in Endocrinology
  89. Comparison of Control‐IQ and open‐source AndroidAPS automated insulin delivery systems in adults with type 1 diabetes: The CODIAC study
    Quoc Dat Do, Aneta Hašková, Lucie Radovnická, Judita Konečná, Eva Horová, Christopher G. Parkin, George Grunberger, Martin Prázný, Jan Šoupal · 2023 · Diabetes Obesity and Metabolism
  90. A multivariate physiological model of vagus nerve signalling during metabolic challenges in anaesthetised rats for diabetes treatment
    Amparo Güemes, Alejandro Carnicer‐Lombarte, Sam Hilton, George G. Malliaras · 2023 · Journal of Neural Engineering
  91. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial
    Tom Wilkinson, Dunya Tomic, Erin Boyle, David Burren, Yasser Elghattis, Alicia Josephine Jenkins, Celeste Keesing, Sonia Middleton, Natalie Nanayakkara, Jonathan A. Williman et al. · 2024 · BMJ Open
  92. Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial
    Anders L. Carlson, Timothy E. Graham, Halis Kaan Aktürk, David R. Liljenquist, Richard M. Bergenstal, Becky Sulik, Viral N. Shah, Mark Sulik, Peter Zhao, Peter Briggs et al. · 2024 · Journal of Diabetes Science and Technology
  93. Protocol for a prospective, multicenter, parallel-group, open-label randomized controlled trial comparing standard care with Closed lOoP In chiLdren and yOuth with Type 1 diabetes and high-risk glycemic control: the CO-PILOT trial
    Alisa Boucsein, Yongwen Zhou, Jillian Joy Haszard, Craig Jefferies, Esko J. Wiltshire, Sara E. Styles, Hamish R. Crocket, Barbara C. Galland, Maheen Pasha, Goran Petrovski et al. · 2024 · Journal of Diabetes & Metabolic Disorders
  94. Turning the tides: achieving rapid and safe glucose control in adolescents with suboptimally controlled type 1 diabetes using advanced hybrid closed loop systems
    Valeria Castorani, Andrea Rigamonti, Giulio Frontino, Elisa Morotti, Federica Sandullo, Francesco Scialabba, Francesca Arrigoni, Benedetta Dionisi, Riccardo Foglino, Camilla Morosini et al. · 2024 · Frontiers in Endocrinology
  95. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes
    Arzu Jalilova, Birsen Şentürk Pilan, Günay Demir, Burcu Özbaran, Hanife Gül Balkı, Emrullah Arslan, Sezen Köse, Samim Özen, Şükran Darcan, Damla Gökşen · 2024 · European Journal of Pediatrics
  96. Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review
    Chiara Mameli, Giulia Marie Smylie, Marco Marigliano, Luca Zagaroli, Valentina Mancioppi, Claudio Maffeis, Vincenzo Salpietro, Gianvincenzo Zuccotti, Maurizio Delvecchio · 2024 · Diabetes Therapy
  97. Miniaturized Neural Networks for Deploying Fully Closed Loop Insulin Delivery Systems: A Pilot Study Featuring Flexible Meal Announcement Options
    Elliott C. Pryor, Marcela Moscoso-Vásquez, David Fulkerson, Viola F. Holmes, Sara Davis Prince, Chaitanya L.K. Koravi, Anas El Fathi, Sue A. Brown, Mark Daniel DeBoer, Marc D. Breton · 2025 · Journal of Diabetes Science and Technology
  98. Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes
    Mary Dena, Ann‐Marie Svensson, Katarina Eeg-Olofson, Laura Young, Anders L. Carlson, Kellee M. Miller, Julia M. Grimsmann, Reinhard Welp, Julia Katharina Mader, David M. Maahs et al. · 2021 · Diabetes Therapy
  99. Telehealth Technologies and Their Benefits to People With Diabetes
    Chinenye O. Usoh, Kristine Kilen, Carolyn Keyes, Crystal Paige Johnson, Joseph Aloi · 2022 · Diabetes Spectrum
  100. Continuous Subcutaneous Insulin Infusions: Closing the Loop
    Carlos A. Díaz-Balzac, David Pillinger, Steven D. Wittlin · 2022 · The Journal of Clinical Endocrinology & Metabolism